CLINICAL_TRIALS
trial_result
· 2024-03-04
Clinical Trial Update: T790M Plasma Testing Methodology Comparison and Clinical Validation [Phase 3]
Summary
Phase 3 clinical trial update comparing T790M plasma testing methodology with clinical validation in lung cancer patients.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: AstraZeneca | Conditions: Lung Cancer | Phase 3 | Status: COMPLETED | Results posted: 2024-03-04